According to GPT3. Adjusted Probability for ISLA-101
Given that ISLA-101 has an established safety profile and is repurposed, its probability of Phase 2b success is likely higher than industry averages.
Final Probability Estimate:
✅ Base Case:50%–60% success rate
✅ Optimistic Case (strong antiviral activity):65%–75% success rateConclusion: ILA’s Phase 2b trial has a solid chance of success, with at least a 50%–60% probability, increasing if early efficacy signals are strong.
According to GPT3. Adjusted Probability for ISLA-101Given that...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
-0.015(10.0%) |
Mkt cap ! $31.87M | |||
| Open | High | Low | Value | Volume |
| 15.0¢ | 15.0¢ | 13.0¢ | $111.7K | 799.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 100000 | 13.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 14.0¢ | 125000 | 2 |
View Market Depth
| Last trade - 15.30pm 19/06/2025 (20 minute delay) ? |
| ILA (ASX) Chart |